RANK ligand inhibition by denosumab prevents cortical bone loss in a murine model of glucocorticoid-induced osteoporosis

被引：0
|
作者：
Hofbauer, L. C. [1 ]
Zeitz, U. [2 ]
Schoopet, M. [1 ]
Skalicky, M. [2 ]
Stolina, M. [3 ]
Kostenuik, P. J. [3 ]
Erben, R. G. [2 ]
机构：
[1] Univ Marburg, Marburg, Germany
[2] Univ Vet Med, Vienna, Austria
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1009
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Inhibition of RANK ligand prevents bone loss and vascular calcium deposition in a murine model of glucocorticoid-induced osteoporosis
    Finger, S.
    Goettsch, C.
    Schoppet, M.
    Hempel, U.
    Morawietz, H.
    Kostenuik, P.
    Erben, R.
    Hofbauer, L.
    BONE, 2009, 44 (02) : S447 - S447
  • [2] Denosumab for glucocorticoid-induced osteoporosis
    Ian R. Reid
    Nature Reviews Endocrinology, 2018, 14 : 383 - 384
  • [3] Denosumab for glucocorticoid-induced osteoporosis
    Reid, Ian R.
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (07) : 383 - 384
  • [4] Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro
    Hyung-Young Yoon
    Ye-Yeon Won
    Yoon-Sok Chung
    Journal of Bone and Mineral Metabolism, 2012, 30 : 509 - 516
  • [5] Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro
    Yoon, Hyung-Young
    Won, Ye-Yeon
    Chung, Yoon-Sok
    JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (05) : 509 - 516
  • [6] Cortical bone is superior to trabecular as an indicator of glucocorticoid-induced vertebral osteoporosis in a murine model.
    Salmon, PL
    Baeyens, O
    Souza, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S436 - S436
  • [7] Denosumab in the treatment of glucocorticoid-induced osteoporosis
    Ilke Coskun Benlidayi
    Rheumatology International, 2018, 38 : 1975 - 1984
  • [8] Denosumab in the treatment of glucocorticoid-induced osteoporosis
    Benlidayi, Ilke Coskun
    RHEUMATOLOGY INTERNATIONAL, 2018, 38 (11) : 1975 - 1984
  • [9] Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats
    Dalle Carbonare L.
    Bertoldo F.
    Valenti M.T.
    Zordan S.
    Sella S.
    Fassina A.
    Turco G.
    Realdi G.
    Lo Cascio V.
    Giannini S.
    Journal of Endocrinological Investigation, 2007, 30 (9) : 739 - 746
  • [10] The therapeutic efficacy of denosumab for the loss of bone mineral density in glucocorticoid-induced osteoporosis: a meta-analysis
    Yamaguchi, Yuta
    Morita, Takayoshi
    Kumanogoh, Atsushi
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2020, 4 (01)
12345